老年急诊患者身体与化学约束的需求率、危险因素及预后:EDEN-50研究
该多中心回顾性观察研究纳入2019年4月1日至7日52家西班牙急诊科连续就诊的25,321例65岁以上患者,分析身体和化学约束的使用率、独立预测因素及对临床预后(死亡、入院、住院时间)的影响。约束使用率0.43%(109例),化学约束0.35%(89例)多于身体约束0.14%(36例),16例同时接受两种约束。急性意识模糊或定向障碍(aOR 6.80;95%CI 4.30-10.76)、救护车送达(aOR 3.43;95%CI 2.08-5.67)和谵妄病史(aOR 3.25;95%CI 1.96-5.38)是独立预测因素。约束使用与全因死亡率升高(aOR 2.14;95%CI 1.19-3.85)及急诊和住院时间延长独立相关。
要点
- 65岁以上急诊患者约束使用率0.43%(109/25,321),化学约束0.35%(89例)多于身体约束0.14%(36例)。
- 急性意识模糊或定向障碍者约束风险最高(aOR 6.80;95%CI 4.30-10.76),其次为救护车送达(aOR 3.43;95%CI 2.08-5.67)和谵妄病史(aOR 3.25;95%CI 1.96-5.38)。
- 约束使用与全因死亡率升高独立相关(aOR 2.14;95%CI 1.19-3.85)。
- 约束使用与急诊时间延长(aOR 2.52;95%CI 1.61-3.95)和住院时间延长(aOR 2.34;95%CI 1.41-3.88)独立相关。
- 约束患者年龄更高(中位86 vs 78岁)、认知障碍比例更高(54.1% vs 13.2%)、养老院居住比例更高(28.4% vs 6.0%)。
适用人群与场景
- 2019年4月1日至7日连续就诊于52家西班牙急诊科的65岁及以上患者,共25,321例。
研究设计与关键结果
- 研究类型:观察性、分析性、回顾性、多中心研究(EDEN-50研究),52家西班牙急诊科,2019年4月1日至7日连续纳入25,321例65岁及以上患者。
- 主要结局为约束需求(分为化学约束和身体约束);约束使用率0.43%(109例),化学约束0.35%(89例),身体约束0.14%(36例),16例同时接受两种约束。
- 约束患者中位年龄86岁 vs 非约束78岁(p<0.001),既往认知障碍54.1% vs 13.2%(p<0.001),养老院居住28.4% vs 6.0%(p<0.001)。
- 急性意识模糊或定向障碍者约束风险aOR 6.80(95%CI 4.30-10.76),救护车送达aOR 3.43(95%CI 2.08-5.67),谵妄病史aOR 3.25(95%CI 1.96-5.38)。
- 机构化居住和高共病与身体约束而非化学约束相关。
- 约束使用与全因死亡率升高独立相关(aOR 2.14;95%CI 1.19-3.85)。
- 约束使用与急诊时间延长独立相关(aOR 2.52;95%CI 1.61-3.95),与住院时间延长独立相关(aOR 2.34;95%CI 1.41-3.88)。
证据类型、等级与局限
- 证据类型:观察性、分析性、回顾性、多中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 急诊科对高龄、认知障碍、到达时精神状态改变的患者使用约束,可识别出死亡和住院时间延长风险较高的患者表型,约束可作为即将死亡和住院时间延长的哨兵标志。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Physical and chemical restraints are used in Emergency Departments (EDs) to manage agitation in older people; however their prevalence and impact on clinical outcomes in this specific setting remain under-researched. Therefore, the aim of this study was analyze the prevalence, identify independent predictors, and evaluate the impact on clinical prognosis (mortality, admission, and length of stay) of physical and chemical restraint use in a large cohort of older patients.
METHODS: An observational, analytical, retrospective, multicenter study (EDEN-50 Study) was conducted across 52 Spanish EDs between 1 and 7 April 2019. We consecutively included 25,321 consecutive patients aged 65 years or older. The primary outcome was the need for restraint, subdivided into chemical and physical modalities. Multivariate logistic regression analysis was performed to determine independent predictors, and models were adjusted to quantify the association with adverse outcomes (all-cause mortality, ED and hospital length of stay).
RESULTS: Restraint use was recorded in 109 patients (0.43%), with a predominance of chemical (0.35%; n = 89) over physical restraint (0.14%; n = 36), including 16 patients who received both. Restrained patients exhibited a more vulnerable profile: higher median age (86 vs. 78 years; p < 0.001), previous cognitive impairment (54.1% vs. 13.2%; p < 0.001), and nursing home residence (28.4% vs. 6.0%; p < 0.001). Patients presenting with acute confusion or disorientation had the highest risk of restraint (aOR 6.80; 95% CI 4.30-10.76), followed by arrival by ambulance (aOR 3.43; 95% CI 2.08-5.67) and a history of delirium (aOR 3.25; 95% CI 1.96-5.38)). Institutionalization and high comorbidity were associated with physical rather than chemical restraint. Restraint use was independently associated with higher all-cause mortality (aOR 2.14; 95% CI 1.19-3.85) and prolonged ED and hospital length of stay (aOR 2.52; 95% CI 1.61-3.95 and aOR 2.34; 95% CI 1.41-3.88, respectively).
CONCLUSIONS: The use of restraint in the ED identifies a specific patient phenotype-advanced age, with cognitive impairment and altered mental status upon arrival-and serves as a sentinel marker for imminent mortality and prolonged ED and hospital length of stay.
参考来源
- Llorens P, Cano S, Espinosa B, et al. Prevalence, risk factors, and prognosis of the need for physical and chemical restraint in older patients attending emergency departments. EDEN-50. Am J Emerg Med. 2026. PMID: 42000676. doi:10.1016/j.ajem.2026.03.029
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。